Font Size: a A A

Value Of PET/MR-IVIM In Predicting Early Prognosis Of Patients With Concurrent Chemoradiotherapy For Cervical Cancer

Posted on:2022-07-27Degree:MasterType:Thesis
Country:ChinaCandidate:Y T LiFull Text:PDF
GTID:2504306563455834Subject:Medical imaging and nuclear medicine
Abstract/Summary:PDF Full Text Request
Objective:To evaluate the value of PET/MR multiple parameters before treatment and MR-intravoxel incoherent motion(IVIM)parameters 4 weeks after concurrent chemoradiotherapy(CCRT)in predicting the prognosis of cervical cancer patients 6months after treatment.Material and Methods:From September 2017 to March 2019,58 cervical cancer patients(age:35-78 years)performed CCRT in Shengjing Hospital of China Medical University were retrospectively enrolled.PET/MR was performed before treatment,and MR-IVIM was performed at the end of the fourth week of treatment and 6 months after treatment.Patients were divided into complete response(CR)group and non-CR group according to the response evacuation criteria in solid tumors(RECIST).PET imaging parameters(maximum standardized uptake value(SUVmax),metabolic tumor volume(MTV),total lesion glycolysis(TLG)),MR-IVIM parameters(slow diffusion coefficient(D),fast diffusion coefficient(D*),perfusion fraction(F),gross tumor volume(GTV),diffusion volume(DV)before(referred to as 1)and after(referred to as 2)treatment and their percentage changes(ΔD,ΔD*,ΔF,ΔGTV,ΔDV)were measured.The parameters of PET and MR-IVIM were analyzed by the receiver operating characteristic(ROC) curve.Multiple logistic regression was used to establish the combination prediction model of parameters before treatment and all parameters before and during treatment(respectively Combination1and Combination2),and the two models were compared by De Long test.Results:Of 58 patients,37(63.79%)were CR,and 21(36.21%)were non-CR.MTV(area under curve(AUC)=0.764,P<0.01),TLG(AUC=0.719,P<0.01),GTV1(AUC=0.761,P<0.01)and DV1(AUC=0.785,P<0.01)before treatment had positive effects on the treatment response,and the valuable parameters after treatment were D2(AUC=0.683,P=0.02),GTV2(AUC=0.861,P<0.01),DV2(AUC=0.891,P<0.01),ΔD(AUC=0.723,P<0.01),ΔGTV(AUC=0.768,P<0.01)andΔDV(AUC=0.865,P<0.01).The best prediction model before treatment was DV1(Combination1;AUC=0.785,P=0.004).The best prediction model for all parameters before and after treatment was the combination of MTV,DV2andΔD(Combination2;AUC=0.965,P<0.001).Combination2was superior to Combination1(z=2.982,P=0.003).Conclusion:In evaluating the early prognosis of cervical cancer patients treated with CCRT,DV1has good predictive potential before treatment,while the combination of pre-treatment MTV with post-treatment DV2andΔD has superior joint predictive potential and can provide help for patients’ personalized treatment.
Keywords/Search Tags:Cervical cancer, concurrent chemoradiotherapy, diffusion volume, early prognosis, PET/MRI
PDF Full Text Request
Related items
Application Of MRI In Predicting The Prognosis Of Neoadjuvant Therapy And Concurrent Chemoradiotherapy In Stage Ⅰ B2 And Ⅱ A2 Cervical Cancer
The Prognostic Value Of Tumor Volume And Tumor Volume Reduction Rate During The Course Of Treatment In Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy
The Combined Predictive Value Of PET And MR-IVIM For The Early Treatment Response And Recurrence Of Locally Advanced Cervical Cancer After Concurrent Chemoradiotherapy
Predictive Value Of Multiparameter Magnetic Resonance Imaging And Clinical Prognostic Factors On The Early Efficacy Of Concurrent Chemoradiotherapy For Cervical Squamous Cell Carcinoma
Study On The Long-term Effect And Prognosis Of Concurrent Chemoradiotherapy And Surgical Comprehensive Treatment For Stage ⅡB Cervical Cancer
Comparison Of The ⅡB And ⅢB Cervical Squamous Cell Carcinoma Efficacy And Prognosis Of Concurrent Chemoradiotherapy Concurrent Chemoradiotherapy After Neoadjuvant Chemotherapy
An Integrative Research Of Immune Surveillance Of Concurrent Chemoradiotherapy For Locally Advanced Cervical Cancer
To Explore The Value Of PET/MR Radiomics In Predicting The Early Response To Concurrent Chemoradiotherapy In Patients With Locally Advanced Cervical Cancer
Prognostic Value Of ADC Quantification For Clinical Outcome In Locally Advanced Cervical Cancer Treated With Concurrent Chemoradiotherapy
10 Part â… :Preliminary Study Of Serum MicroRNAs Related To The Sensitivity To Concurrent Chemoradiotherapy In Advanced Cervical Squamous Cell Carcinoma Part â…¡:Clinical Analysis Of 32 Cases With Neuroendocrine Carcinoma Of The Uterine Cervix In Early-Stage